Literature DB >> 28093702

Rabies virus vaccine as an immune adjuvant against cancers and glioblastoma: new studies may resurrect a neglected potential.

M A Altinoz1, S Guloksuz2,3, I Elmaci4.   

Abstract

To review the literature about the use of Rabies Virus-Vaccine (RV-V) as an anticancer immunotherapeutic modality in the light of recent findings. The literature search in relevant databases with the following key words: Rabies virus, cancer, remission. Remissions occured following RV-V injections in patients with cervical cancer and melanoma. Pilot clinical studies showed that RV-V injections enhanced survival in glioblastoma patients, which is supported by findings in GL261 mouse glioma model. If public health studies demonstrate protective role of RV-V against certain types of cancers, it can be benefitted as a novel immune adjuvant in clinic.

Entities:  

Keywords:  Cancer; Immunotherapy; Rabies virus; Spontaneous remission

Mesh：

Substances：

Year:  2017        PMID： 28093702     DOI： 10.1007/s12094-017-1613-6

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN： 1699-048X            Impact factor:   3.405


  32 in total

1.  Involvement of the rabies virus phosphoprotein gene in neuroinvasiveness.

Authors:  Satoko Yamaoka; Naoto Ito; Seii Ohka; Shohei Kaneda; Hiroko Nakamura; Takahiro Agari; Tatsunori Masatani; Keisuke Nakagawa; Kazuma Okada; Kota Okadera; Hiromichi Mitake; Teruo Fujii; Makoto Sugiyama
Journal:  J Virol       Date:  2013-09-11       Impact factor: 5.103

2.  A preliminary study of chemo- and cytokine responses in rabies vaccine recipients of intradermal and intramuscular regimens.

Authors:  Abhinbhen Saraya; Supaporn Wacharapluesadee; Pakamatz Khawplod; Saowaluck Tepsumethanon; Deborah Briggs; Thanin Asawavichienjinda; Thiravat Hemachudha
Journal:  Vaccine       Date:  2010-05-12       Impact factor: 3.641

3.  [A trial of rabies vaccine treatment of patients with glioblastoma multiforme].

Authors:  F V Filipov
Journal:  Zh Vopr Neirokhir Im N N Burdenko       Date:  1988 May-Jun

Review 4.  Replication strategies of rabies virus.

Authors:  Stefan Finke; Karl-Klaus Conzelmann
Journal:  Virus Res       Date:  2005-08       Impact factor: 3.303

5.  Three dimensional morphology of rabies virus studied by cryo-electron tomography.

Authors:  Paul Guichard; Tino Krell; Michel Chevalier; Carole Vaysse; Olivier Adam; Frédéric Ronzon; Sergio Marco
Journal:  J Struct Biol       Date:  2011-07-19       Impact factor: 2.867

6.  [Autoantibodies directed against membrane phospholipid in serum in patients with malignant tumors].

Authors:  S Faiderbe; J L Chagnaud; J Wafflart; M Geffard
Journal:  C R Acad Sci III       Date:  1989

Review 7.  The sweet and sour of cancer: glycans as novel therapeutic targets.

Authors:  Mark M Fuster; Jeffrey D Esko
Journal:  Nat Rev Cancer       Date:  2005-07       Impact factor: 60.716

8.  RVG-peptide-linked trimethylated chitosan for delivery of siRNA to the brain.

Authors:  Yikun Gao; Zhan-You Wang; Jinghai Zhang; Youxi Zhang; Hong Huo; Tianyi Wang; Tongying Jiang; Siling Wang
Journal:  Biomacromolecules       Date:  2014-02-27       Impact factor: 6.988

9.  Peptides that mimic the amino-terminal end of the rabies virus phosphoprotein have antiviral activity.

Authors:  Guillaume Castel; Mohamed Chtéoui; Grégory Caignard; Christophe Préhaud; Stéphanie Méhouas; Eléonore Réal; Corinne Jallet; Yves Jacob; Rob W H Ruigrok; Noël Tordo
Journal:  J Virol       Date:  2009-08-12       Impact factor: 5.103

10.  Association between Prediagnostic Allergy-Related Serum Cytokines and Glioma.

Authors:  Judith Schwartzbaum; Michal Seweryn; Christopher Holloman; Randall Harris; Samuel K Handelman; Grzegorz A Rempala; Ruo-Pan Huang; Brett Burkholder; Adam Brandemihl; Henrik Kallberg; Tom Borge Johannesen; Anders Ahlbom; Maria Feychting; Tom K Grimsrud
Journal:  PLoS One       Date:  2015-09-09       Impact factor: 3.240
View more
  1 in total

Review 1.  Overcoming the blood-brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches.

Authors:  Ksenia Mitusova; Oleksii O Peltek; Timofey E Karpov; Albert R Muslimov; Mikhail V Zyuzin; Alexander S Timin
Journal:  J Nanobiotechnology       Date:  2022-09-15       Impact factor: 9.429
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.